INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 32 filers reported holding INMUNE BIO INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $937,000 | -34.0% | 151,100 | -5.9% | 1.29% | -34.9% |
Q2 2022 | $1,419,000 | -26.9% | 160,500 | -30.4% | 1.98% | -3.4% |
Q1 2022 | $1,941,000 | -17.4% | 230,500 | 0.0% | 2.05% | +20.8% |
Q4 2021 | $2,351,000 | -56.0% | 230,500 | -16.2% | 1.70% | -38.6% |
Q3 2021 | $5,341,000 | – | 275,000 | – | 2.77% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 230,500 | $2,351,000 | 1.70% |
Fermata Advisors, LLC | 17,955 | $183,000 | 0.07% |
Virtu Financial LLC | 24,364 | $249,000 | 0.02% |
YorkBridge Wealth Partners, LLC | 10,369 | $106,000 | 0.02% |
Jump Financial, LLC | 21,100 | $215,000 | 0.01% |
Financial Advocates Investment Management | 15,167 | $155,000 | 0.01% |
FNY Investment Advisers, LLC | 1,100 | $11,000 | 0.01% |
Janney Montgomery Scott LLC | 113,914 | $1,162,000 | 0.01% |
Walleye Capital LLC | 17,127 | $175,000 | 0.01% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 12,473 | $127,000 | 0.00% |